Epitomics Inc.

The story of the Rabbit MonoClonal Antibody Company



00:09:54 - Uploaded by Essinova on May 9, 2009

With proven success of the Rabbit MonoClonal Antibody technology in research and diagnostics, Epitomics is poised to brave the development of therapeutics.

Tags: MonoClonal, antibody, reagent, diagnostics, therapeutics, China



There are 1 comments. You must be logged in to comment.

  • Li Yan says:

    June 8, 2009

    Very impressive technology breakthroughs. Now the real test is whether Epitomics can jump out of being a provider of antibodies for assays and transform to a company develops therapeutics. We look forward to seeing one of these rabbit-human antibodies entering clinical trial in the near future.

Discovery & Development

 photo Essinova-Brain-and-Mind-banner_iStock_000004422514Medium.jpg

 photo Essinova_Art-and-Science-banner_PIA09962.jpg